As at Jun 26, 2025, the TECH stock has a PE ratio of 63.61. This is based on the current EPS of $0.83 and the stock price of $52.8 per share. A decrease of 13% has been seen in the P/E ratio compared to the average of 73.4 of the last 4 quarters.
The mean historical PE ratio of BIO-TECHNE over the last ten years is 57.36. The current 63.61 PE ratio is 11% above the historical average. Over the past ten years, TECH's PE ratio was at its highest in the Jun 2021 quarter at 123.7, with a price of $112.57 and an EPS of $0.91. The Sep 2015 quarter recorded the bottom point at 32.1, with a price of $23.12 and an EPS of $0.72.
Maximum annual increase: 181.07% in 2021
Maximum annual decrease: -59.51% in 2022
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 66.96 | 48.47% | $71.65 | $1.07 |
2023 | 45.1 | -9.96% | $81.63 | $1.81 |
2022 | 50.09 | -59.51% | $86.66 | $1.73 |
2021 | 123.7 | 181.07% | $112.57 | $0.91 |
2020 | 44.01 | -45.96% | $66.02 | $1.5 |
2019 | 81.44 | 84.96% | $52.12 | $0.64 |
2018 | 44.03 | -23.56% | $36.99 | $0.84 |
2017 | 57.6 | 43.03% | $29.38 | $0.51 |
2016 | 40.27 | 19.42% | $28.19 | $0.7 |
2015 | 33.72 | 9.27% | $24.62 | $0.73 |
2014 | 30.86 | 37.58% | $23.14 | $0.75 |
2013 | 22.43 | -8.11% | $17.27 | $0.77 |
2012 | 24.41 | -11.01% | $18.55 | $0.76 |
2011 | 27.43 | 41.32% | $20.84 | $0.76 |
2010 | 19.41 | -14.83% | $14.36 | $0.74 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 70.64 | -1.93% | $58.63 | $0.83 |
Dec 2024 | 72.03 | -14.39% | $72.03 | $1 |
Sep 2024 | 84.14 | 25.66% | $79.93 | $0.95 |
Jun 2024 | 66.96 | 20.8% | $71.65 | $1.07 |
Mar 2024 | 55.43 | 1.3% | $70.39 | $1.27 |
Dec 2023 | 54.72 | 25.42% | $77.16 | $1.41 |
Sep 2023 | 43.63 | -3.26% | $68.07 | $1.56 |
Jun 2023 | 45.1 | 5.18% | $81.63 | $1.81 |
Mar 2023 | 42.88 | -13.6% | $74.19 | $1.73 |
Dec 2022 | 49.63 | 30.02% | $82.88 | $1.67 |
Sep 2022 | 38.17 | -23.8% | $71 | $1.86 |
Jun 2022 | 50.09 | -32.91% | $86.66 | $1.73 |
Mar 2022 | 74.66 | -22.07% | $108.26 | $1.45 |
Dec 2021 | 95.8 | -9.84% | $129.34 | $1.35 |
Sep 2021 | 106.26 | -14.1% | $121.14 | $1.14 |
The current PE ratio of TECH is greater than its 3 and 10-year historical averages, but it is below the 5-year average.
TECH's PE ratio is lower than its peer stock QGEN, but it is greater than GE's and TMO's. BIO-TECHNE is presently trading at a higher PE ratio (63.61) than its peer group average of 33.62.
Stock name | PE ratio | Market cap |
---|---|---|
TMO Thermo Fisher Scientific Inc | 24.1 | $155.51B |
BDX Becton Dickinson & Co | 33.11 | $49.16B |
DHR Danaher Corp | 38.62 | $143.45B |
GE General Electric Co | 39.63 | $273.87B |
TECH BIO-TECHNE Corp | 62.35 | $8.11B |
QGEN Qiagen NV | 111.58 | $10.44B |
BIO Bio-Rad Laboratories Inc | N/A | $6.59B |
STEM Stem Inc | N/A | $1.16B |
The price to earnings ratio for TECH stock as of Jun 26, 2025, stands at 63.61.
Over the last 3 years, the average price to earnings ratio for TECH stock is 56.12.
Over the last 5 years, the average price to earnings ratio for TECH stock is 65.26.
In the last ten years, the Jun 2021 quarter recorded the highest quarterly PE ratio at 123.7.
TECH's current price to earnings ratio is 11% above its 10-year historical average.
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jun 26, 2025), BIO-TECHNE's stock price is $52.8. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.83. Therefore, BIO-TECHNE's P/E ratio for today is 63.61. PE RATIO(63.61) = STOCK PRICE($52.8) / TTM EPS($0.83)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.